Business Context and Reporting Period
Company: Biorestorative Therapies, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 25, 2014
Reporting Period: Events occurring between August 21, 2014, and August 29, 2014.
The Company is relocating its corporate and laboratory operations from Jupiter, Florida, to a new facility in Melville, Long Island, New York.
Key Financial Metrics and Obligations
This filing does not report revenue, profit, cash flow, or margins. It details specific financial obligations and equity issuances:
- Lease Obligation: A five-year, three-month lease for 6,800 square feet with an aggregate base rental of approximately $693,000 during the initial term. Annual base rental ranges between $132,600 and $149,260.
- Equity Issuances (Cash): 384,200 shares issued for an aggregate purchase price of $101,050.
- Equity Issuances (Services): 300,000 shares issued for services valued at $75,000.
- Debt Settlement: 120,000 shares issued to settle outstanding indebtedness of approximately $21,288 (inclusive of accrued interest).
- Warrants Issued: Warrants to purchase an aggregate of 167,100 shares at exercise prices ranging from $0.50 to $0.75 per share.
Material Changes
Operational Relocation: The Company entered into a definitive lease agreement to move operations to New York, with commencement anticipated around September 30, 2014, following facility improvements.
Capital Structure Changes: Significant dilution occurred through the issuance of 804,200 shares of common stock and 167,100 warrants in late August 2014 to secure the new lease, raise capital, pay for services, and settle debt.
Guidance, Risks, and Unusual Items
Unusual Items: The Company issued equity to the principals of the landlord in consideration of lease concessions valued at $71,050. This included 284,200 shares and warrants for 142,100 shares.
Risks and Contingencies: The filing notes reliance on Section 4(a)(2) of the Securities Act for unregistered sales, asserting that investors are accredited and had access to Company information. No forward-looking financial guidance or revenue outlook is provided in this report.
Investor Verification Checklist
- Verify the completion of facility improvements at 40 Marcus Drive, Melville, NY, to confirm the lease commencement date.
- Review the impact of the 804,200 newly issued shares on existing shareholder dilution.
- Confirm the valuation of the $71,050 lease concessions and the associated warrant terms.
- Assess the Company's liquidity position following the settlement of $21,288 in debt via equity conversion.
- Check subsequent filings for the actual move date and any changes to the $693,000 rental obligation.